Table 2.
The spatial analysis of five category cardiovascular medications by urbanicity, data presented as N (%)
| Group Ad | Group B | Group C | Group D | Group O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ha | Lb | H | L | H | L | H | L | H | L | |
| Taipei-Keelung metropolitan area (N = 44) | 1 (2.3) | 4 (9.1) | 0 (0.0) | 2 (4.5) | 0 (0.0) | 4 (9.1) | 1 (2.3) | 3 (6.8) | 0 (0.0) | 5 (11.4) |
| Hsinchu secondary metropolitan Area (N = 10) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 0 (0.0) | 3 (30.0) | 0 (0.0) | 0 (0.0) |
| Tainan metropolitan area (N = 14) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (14.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (14.3) | 0 (0.0) | 0 (0.0) |
| Kaohsiung metropolitan area (N = 28) | 2 (7.1) | 1 (3.6) | 3 (10.7) | 2 (7.1) | 4(14.3) | 3 (10.7) | 4 (14.3) | 1 (3.6) | 2(7.1) | 1 (3.6) |
| Rural townships area (N = 167) | 3 (1.7) | 7 (4.0) | 3 (1.7) | 7 (4.0) | 4 (2.3) | 6 (3.5) | 2 (1.2) | 6 (3.5) | 1 (0.6) | 6 (3.5) |
| Aboriginal townships area (N = 55) | 0 (0.0) | 5 (9.1) | 1 (1.8) | 4 (7.3) | 1 (1.8) | 4 (7.3) | 2 (3.6) | 2 (3.6) | 1 (1.8) | 4 (7.3) |
| Total (N = 352)c | 6 (1.7) | 17 (4.8) | 7 (2.0) | 17 (4.8) | 9 (2.6) | 18 (5.1) | 9 (2.6) | 17 (4.8) | 4 (1.1) | 16 (4.5) |
a. High-high association (hot spot), meanings utilization was higher than average
b. Low-low association (cold spot), meanings utilization was lower than average
c. Three areas did not presented any hot spot or cold spot including Taichung-Changhwa metropolitan, Chungli-Taoyuan metropolitan, and Chiayi secondary metropolitan areas.
d. Group A, agents acting on the rennin-angiotensin system; Group B, beta blocking agents; Group C, calcium channel blockers; Group D, diuretics; Group O, antihypertensives